Xu, J.-Y.; Tian, M.-Q.; Yang, R.; Li, Z.-X.; Lin, Z.-H.; Wang, Y.-F.; Chu, Y.-H.; Sun, W.-N.; Wang, Y.-M.
Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 713.
https://doi.org/10.3390/ijms27020713
AMA Style
Xu J-Y, Tian M-Q, Yang R, Li Z-X, Lin Z-H, Wang Y-F, Chu Y-H, Sun W-N, Wang Y-M.
Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. International Journal of Molecular Sciences. 2026; 27(2):713.
https://doi.org/10.3390/ijms27020713
Chicago/Turabian Style
Xu, Jun-Yi, Mao-Qi Tian, Rui Yang, Zi-Xuan Li, Zi-Heng Lin, Yu-Fei Wang, Yu-Hang Chu, Wei-Ning Sun, and Ya-Mei Wang.
2026. "Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer" International Journal of Molecular Sciences 27, no. 2: 713.
https://doi.org/10.3390/ijms27020713
APA Style
Xu, J.-Y., Tian, M.-Q., Yang, R., Li, Z.-X., Lin, Z.-H., Wang, Y.-F., Chu, Y.-H., Sun, W.-N., & Wang, Y.-M.
(2026). Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. International Journal of Molecular Sciences, 27(2), 713.
https://doi.org/10.3390/ijms27020713